See also:
When a woman asks if it is safe to take a particular drug during pregnancy, there is rarely a definite yes or no answer. The key to taking medicines during pregnancy—or when you are trying to get pregnant—is weighing the benefits of the medicine against the potential risks to the fetus.
When possible, think ahead. It is best to address questions about medicines and vitamins before you are pregnant. Ask your doctor about the over-the-counter medicines you currently use. These include drugs for everyday conditions, such as heartburn, allergies, or headaches. In addition, check with your doctor about any prescription medicines you are taking. Both types of medicines may need to be either discontinued or changed before you get pregnant.
Not long ago, many women with chronic conditions, such as lupus or diabetes, considered pregnancy to be too risky. However, because of advances in the fields of high risk obstetrics and internal medicine, many of these women now deliver healthy babies. Sandra Gangell, of the Pregnancy Risk Network of People, Inc., encourages women with chronic health problems to assemble a healthcare team to help them manage their disease processes and medicines during this important time. Ideally, the team should be formed before conception. She also states that enlisting a teratology specialist is particularly important, as these doctors specialize in understanding how medicines and other substances effect a developing fetus. Ronald J. Ruggiero, PharmD, of the University of California San Francisco, agrees with Gangell. He notes that obstetricians cannot be expected to know the effects of all medicines used for chronic conditions.
Members of the team may include:
The Organization of Teratology Information Services (OTIS) provides expert information about prenatal exposures to medicines, chemicals, and other substances. OTIS member organizations do not prescribe or recommend treatments; they provide objective information about the following:
The US Food and Drug Administration (FDA) currently requires that drugs be categorized according to their risk to pregnant women.
In some cases, such as when women have asthma, depression, diabetes, high blood pressure, or HIV, stopping medicine may be significantly more harmful to the fetus than taking the drugs during pregnancy. In these types of cases, OTIS can provide information about a specific drug and the risk to the fetus, based on timing during the pregnancy. Some drugs are potentially harmful early in the pregnancy, but not later on. Conversely, others present a greater risk around the time of delivery. OTIS can also inform you about the risk/benefit profile of medicines that can help you manage your condition during pregnancy.
"Don't stop taking medicine for a chronic condition if a home pregnancy test is positive," warns Gangell. Check with your healthcare provider first.
According to Gangell, substances that pose a high risk during pregnancy include the following:
Dr. Ruggiero warns pregnant women not to take herbal remedies or supplements, because there are no reliable studies about their effects during pregnancy. Since they are not regulated the way conventional medicines are, there is no way to gauge the purity or actual dose of the substance you are taking. There may be many alternative and complementary therapies that are safe and/or helpful in pregnancy. But you need to do your research to find out if there is information about their safety in pregnancy, and physicians recommend that you discuss this with them as well.
An excellent resource about both drugs and other supplements is the Mother Risk Program hosted by the Hospital for Sick Children in Toronto, Canada.
Organization of Teratology Information Services (OTIS)
Canadian Association of Family Physicians
Women's Health
Allaire AD, Moos MK, Wells SR. Complementary and alternative medicine in pregnancy: a survey of North Carolina certified nurse-midwives. Obstet Gynecol. 2000;95:19-23.
Gibson PS, Powrie R, Star J. Herbal and alternative medicine use during pregnancy: a cross-sectional survey. Obstet Gynecol. 2001;97:S44-S45.
Meadows M. Pregnancy and the drug dilemma. Food and Drug Administration website. FDA Consumer Magazine. May-June 2001. Available at: http://www.fda.gov/fdac/features/2001/301_preg.html.
Scialli AR. The Organization of Teratology Information Services (OTIS) registry study. Journal of Allergy and Clinical Immunology. 1999;103:373-376.
Last reviewed November 2010 by Brian Randall, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.